Advent Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Advent Pharma has a total shareholder equity of BDT1.5B and total debt of BDT75.3M, which brings its debt-to-equity ratio to 5.1%. Its total assets and total liabilities are BDT1.9B and BDT384.7M respectively. Advent Pharma's EBIT is BDT122.6M making its interest coverage ratio 9.5. It has cash and short-term investments of BDT3.9M.
Key information
5.1%
Debt to equity ratio
৳75.34m
Debt
| Interest coverage ratio | 9.5x |
| Cash | ৳3.92m |
| Equity | ৳1.48b |
| Total liabilities | ৳384.74m |
| Total assets | ৳1.87b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ADVENT's short term assets (BDT257.7M) exceed its short term liabilities (BDT183.4M).
Long Term Liabilities: ADVENT's short term assets (BDT257.7M) exceed its long term liabilities (BDT201.4M).
Debt to Equity History and Analysis
Debt Level: ADVENT's net debt to equity ratio (4.8%) is considered satisfactory.
Reducing Debt: ADVENT's debt to equity ratio has increased from 3.2% to 5.1% over the past 5 years.
Debt Coverage: ADVENT's debt is well covered by operating cash flow (199.7%).
Interest Coverage: ADVENT's interest payments on its debt are well covered by EBIT (9.5x coverage).